Viridian Therapeutics Inc (VRDN) earnings · rev $70.8M
These earnings events as JSON? API free 100/dayViridian Therapeutics Inc (VRDN) is a biotechnology company listed on US.
This VRDN earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported VRDN revenue for 2025-12-31 was $70.8M. Net income was -$342.6M. Revenue was up 23359.9% from 2024-12-31 to 2025-12-31. VRDN currently screens at market cap $1.39B.
When the next VRDN 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was up 23359.9% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full VRDN research stays on the stock page; the tape stays on the quote page.
VRDN earnings FAQ
What are VRDN's latest revenue and net income?
Latest cached Viridian Therapeutics Inc (VRDN) revenue for Dec 31, 2025 was $70.8M. Net income was -$342.6M. Statements: https://lician.com/financials/vrdn
What period does the latest VRDN earnings print cover?
The latest cached Viridian Therapeutics Inc (VRDN) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
How did VRDN revenue change from the prior cached period?
Cached Viridian Therapeutics Inc (VRDN) revenue was up 23359.9% from $302.0K (Dec 31, 2024) to $70.8M (Dec 31, 2025). Statements: https://lician.com/financials/vrdn
Where are VRDN earnings listed?
Cached earnings facts for Viridian Therapeutics Inc (VRDN) are listed at https://lician.com/earnings/vrdn. Statements: https://lician.com/financials/vrdn
Not investment advice.